Therefore, it is significantly important to understand the interactions and kinetic parameters for the advancement of therapeutic and diagnostic strategies in conditions in protein aggregation associated diseases.The effect of these drugs are not directly tested on proteins in other amyloid disease like FAP except lysozyme and Aβ-42 (that is believed to be directly involve in Alzheimer’s) but can be implicate to those. The gene discussed is FAP; the disease is amyloidosis.